Bactroban Nasal Generic Name & Formulations
Mupirocin (as calcium) 2%; oint.
Oint—22g; Crm—15g, 30g; Nasal (single-use) (1g)—10
Bactroban Nasal Indications
Eradication of nasal colonization of methicillin-resistant S. aureus (MRSA) in adult patients and healthcare workers in certain institutional settings during outbreaks of infections with MRSA (see literature).
Bactroban Nasal Dosage and Administration
Apply approximately 0.25g to inside of each nostril twice daily for 5 days. Spread ointment by repeatedly closing and releasing the nostrils for 1 minute after application.
Bactroban Nasal Contraindications
Bactroban Nasal Boxed Warnings
Bactroban Nasal Warnings/Precautions
Avoid eyes. Nasal use in high-risk patients: see full labeling regarding autoinfection. Discontinue if sensitization or severe local irritation occurs. Prolonged use may result in superinfection. Pregnancy. Nursing mothers.
Bactroban Nasal Pharmacokinetics
Bactroban Nasal Interactions
Nasal: avoid other concomitant nasal products.
Bactroban Nasal Adverse Reactions
Topical: burning, stinging, pain, itching. Nasal: headache, rhinitis, respiratory disorder, pharyngitis, taste perversion, burning/stinging, cough, pruritus; severe allergic reactions, C. difficile-associated diarrhea.
Bactroban Nasal Clinical Trials
Bactroban Nasal Note
Bactroban Nasal Patient Counseling